Determinants of performance measures of clinical trials: a study of Indian medical devices industry


  • Naga Rekha Gorantla Centre for Healthy Brain Ageing, University of New South Wales, Sydney, NSW, Australia
  • Bala Subrahmanya Mungila Hillemane Department of Management Studies, Indian Institute of Science, Bengaluru, Karnataka, India



Clinical trials, Sponsorship, Participant recruitment, Locations, Duration, India


Developing new medical devices require extensive clinical investigations to enter the market successfully. In recent years, India has emerged as one of the attractive and most preferred countries to carry out clinical trials, primarily due to diverse human gene pool and cost-competitiveness. However, unlike other healthcare products such as therapeutic drugs, there is a lack of regulations over usage of medical devices. Moreover, prior systematic empirical analysis that examine the medical device based clinical trials is also not well established. This study attempted to ascertain the determinants of participant recruitment, selection of locations and time taken to conduct medical device clinical trials. Medical devices that are clinically tested in India in the period of 2008 to 2014 were obtained from CTRI website. 108 out of 279 records were identified as medical device clinical trial registrations. Collected data was analyzed to know the device type, disease category, sponsors involved, participant enrolment, locations and the duration of the device trial. In this study, the category of sponsorship, device type and disease category were found to have significant influence with respect to the selection of number of participants, locations and the time taken to execute medical device clinical trials.

Author Biographies

Naga Rekha Gorantla, Centre for Healthy Brain Ageing, University of New South Wales, Sydney, NSW, Australia

Centre for Healthy Brain Ageing, UNSW Medical School

Bala Subrahmanya Mungila Hillemane, Department of Management Studies, Indian Institute of Science, Bengaluru, Karnataka, India

Department of Management Studies


Maiti R, Raghavendra M. Clinical trials in India. Pharmacological Research. 2007;56:1-10.

Varawalla N, Jain R. Clinical trials in India. In Global Clin Trials. 2011;119-157.

Chawan VS, Gawand KV, Phatak A. M. Impact of new regulations on clinical trials in India. Int J Clin Trials 2015;2:56-8.

Mondal S, Abrol D. Clinical Trials Industry in India: A Systematic Review. Institute for Studies in Industrial Development; 2015.

Sung NS, Crowley Jr WF, Genel M, Salber P, Sandy L, Sherwood, LM, Larson EL. Central challenges facing the national clinical research enterprise. JAMA. 2003;289:1278-87.

Lang T, Siribaddana S. Clinical trials have gone global: Is this a good thing? PLoS medicine. 2012;9:e1001228.

McDermott PW. Industry Perspective on Clinical Investigative Sites: Maximizing Sponsor Return on Investment; 2010.

Allareddy V, Rampa S, Masoud MI, Lee MK, Nalliah R, Allareddy V. Overview of registered studies in orthodontics: Evaluation of the registry. Am J Orthodontics Dentofacial Orthop. 2014;146:587-93.

Sullivan J. Subject recruitment and retention: Barriers to success. Applied Clin Trials. 2004;13:50–4.

Hunninghake DB, Darby CA, Probstfield JL. Recruitment experience in clinical trials: Literature summary and annotated bibliography. Controlled Clin Trials. 1987;8:6-30.

Pugatch MP, Chu R. The strength of pharmaceutical IPRs vis-à-vis foreign direct investment in clinical research: Preliminary findings. J Commercial Biotechnol. 2011;17:308-18.

Rengerink KO, Opmeer BC, Logtenberg SL, Hooft L, Bloemenkamp KW, Haak MC, van Pampus MG. Improving participation of patients in clinical trials-rationale and design of impact. BMC Med Res Methodol. 2010;10:1-6.

Gul RB, Ali PA. Clinical trials: The challenge of recruitment and retention of participants. J Clin Nursing. 2010;19:227-33.

Martin SS, Ou FS, Newby LK, Sutton V, Adams P, Felker GM, Wang TY. Patient-and trial-specific barriers to participation in cardiovascular randomized clinical trials. J Am Coll Cardiol. 2013;61:762-9.

Goel D. Empowering clinical trial sites with data. Indian Journal of Medical Specialities. 2015;6:161-4.

Thatte UM, Bavdekar SB. Clinical research in India: Great expectations? J Postgraduate Med. 2008;54:318.

Saini KS, Agarwal G, Jagannathan R, Metzger-Filho O, Saini ML, Mistry K, Gupta S. Challenges in launching multinational oncology clinical trials in India. South Asian J Cancer. 2013;2:44-9.

Bernardez-Pereira S, Lopes RD, Carrion MJ, Santucci EV, Soares RM, de Oliveira Abreu M, Cavalcanti AB. Prevalence, characteristics and predictors of early termination of cardiovascular clinical trials due to low recruitment: Insights from the registry. Am Heart J. 2014;168:213-9.

Karlberg JP, Speers MA. Reviewing clinical trials: A guide for the ethics committee. Clinical Trials Centre. Hong Kong; 2010.

Thomas MK, Gupta YK. Drug-eluting stents: A pharmacoclinical perspective. National Med J India. 2006;19:195-9.

Dainty K, Karlsson J. Factors to consider in determining the feasibility of randomized clinical trials. Arthroscopy: J Arthroscopic Related Surg. 2003;19:882-4.

Califf RM, Zarin DA, Kramer JM, Sherman RE, Aberle LH, Tasneem A. Characteristics of clinical trials registered in, 2007-2010. JAMA. 2012;307:1838-47.

Merriel A, Harb HM, Williams H, Lilford R, Coomarasamy A. Global women's health: current clinical trials in low‐and middle‐income countries. BJOG: An Int J Obstetr Gynaecol. 2015;122:190-8.

Todd JL, White KR, Chiswell K, Tasneem A, Palmer SM. Using to understand the state of clinical research in pulmonary, critical care, and sleep medicine. Ann Am Thoracic Society. 2013;10:411-7.

Dear RF, Barratt AL, McGeechan K, Askie L, Simes J, Tattersall MH. Landscape of cancer clinical trials in Australia: Using trial registries to guide future research. Med J Australia. 2011;194:387-91.

Global Harmonization Task Force. Definition of terms, 2012. Available at docs/ghtf/final/sg1/technical-docs/ghtf-sg1-n071-2012-definition-of-terms-120516.docx. Accessed 07 August 2013.

Butler J, Tahhan AS, Georgiopoulou VV, Kelkar A, Lee M, Khan B, Gheorghiade M. Trends in characteristics of cardiovascular clinical trials 2001-2012. American Heart J. 2015;170:263-72.

Burke MJ, Fralick M, Nejatbakhsh N, Tartaglia MC, Tator CH. In search of evidence-based treatment for concussion: Characteristics of current clinical trials. Brain Injury. 2015;29:300-305.

Cihoric N, Tsikkinis A, Miguelez CG, Strnad V, Soldatovic I, Ghadjar P, Lössl K. Portfolio of prospective clinical trials including brachytherapy: An analysis of the database. Radiation Oncol. 2016;11:1-13.

Clinical trials registry of India. Medical device clinical trials search in CTRI, 2014. Available at Accessed 07 August 2013.

Frank G. Current challenges in clinical trial patient recruitment and enrollment. SoCRA Source. 2004;2:30-8.

Whittingham MJ, Stephens PA, Bradbury RB, Freckleton RP. Why do we still use stepwise modelling in ecology and behaviour? J Animal Ecol. 2006;75:1182-9.

Cher DJ, Capobianco RA. Spine device clinical trials: Design and sponsorship. Spine J. 2015;15:1133-40.

Inrig JK, Califf RM, Tasneem A, Vegunta RK, Molina C, Stanifer JW, Patel UD. The landscape of clinical trials in nephrology: A systematic review of Am J Kidney Dis. 2014;63:771-80.






Review Articles